Inteum Company
Links
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - therapeutics+%26+drug+delivery+-+therapeutic
3
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Alginate–Konjac Glucomannan–Calcium Sulfate (AKC) Bioink with Tunable Mechanical Properties for Enhanced 3D Bioprinting and Biocompatibility
AKC bioink combines alginate from Lessonia nigrescens, Konjac Glucomannan, and calcium sulfate to form a biocompatible hydrogel for high-precision 3D bioprinting. Its slow-release CaSO₄ enables volumetric crosslinking, avoiding the surface-only gelation of traditional CaCl₂ systems. KGM improves viscosity, print fidelity, and layer stability, while...
Published: 7/17/2026
|
Updated: 7/17/2026
|
Inventor(s):
Lina Nih
Keywords(s):
Engineering & Manufacturing - Mechanical Engineering
,
Life Science - Biology
,
Life Science - Biotech
,
Therapeutics & Drug Delivery
,
Therapeutics & Drug Delivery - Drug Delivery
,
Therapeutics & Drug Delivery - Therapeutic
Category(s):
Technology Classifications > Life Sciences
,
Technology Classifications > Medical Devices
Thiophosphoric Acids as Novel Organocatalysts and Synthetic Methods of Thiophosphonate derivatives as Pharmaceutical Agents
Title: Thiophosphoric Acids as Novel Organocatalysts and Synthetic Methods of Thiophosphonate derivatives as Pharmaceutical Agents Tech ID: 2022-006 Status: Active Category: Pharmaceutical Chemistry and Organocatalysis Executive Statement: Innovative thiophosphoric acids serve as effective organocatalysts for synthesizing pharmaceutical agents...
Published: 7/16/2026
|
Updated: 4/9/2024
|
Inventor(s):
Jun Yong Kang
,
Jeffrey Ash
Keywords(s):
Chemistry
,
Therapeutics & Drug Delivery - Therapeutic
Category(s):
All
Synthesizing and investigating novel synthetic cannabidiol congeners for enhanced clinical utility
Title: Synthetic Cannabidiol Congeners for Enhanced Clinical Utility Tech ID: 2023-001 Status: Active Category: Pharmaceuticals and Synthetic Cannabinoid Research Executive Statement: Innovative synthetic cannabidiol compounds designed to improve treatment options for seizures, anxiety, and inflammatory conditions. Description: This technology...
Published: 8/4/2026
|
Updated: 3/14/2024
|
Inventor(s):
Rochelle Hines
,
Dustin Hines
,
William Maio
Keywords(s):
Chemistry
,
Life Science
,
Life Science - Health
,
Therapeutics & Drug Delivery
,
Therapeutics & Drug Delivery - Therapeutic
Category(s):
All